‘Generic to genetic’ transition in cardiovascular and neuropsychiatric drugs: opportunity for personalized medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.10, 2012-07, pp. : 1097-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Personalized and Participatory Medicine as a Future Tool to Combat Cardiovascular Disease in Developing Countries

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 3, 2015-03 ,pp. : 133-140

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine

By Umićević Mirkov Maša Coenen Marieke JH

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 425-444

Future Medicine

Access to resources Recommend Favorite

Genetic biomarkers in personalized medicine Genetische Biomarker in der stratifizierten Arzneimitteltherapie

By Dingermann Theo Zündorf Ilse

PHARMAKON, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-20

Govi-Verlag

Access to resources Recommend Favorite

Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 4, 2011-12 ,pp. : 299-322

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics and Personalized Use of Drugs

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 18, 2008-12 ,pp. : 1573-1579

Bentham Science Publishers

Access to resources Recommend Favorite